OmniAb (OABI) Depreciation and Depletion (2022 - 2026)
OmniAb (OABI) reported Depreciation and Depletion of $606000.0 for Q1 2026, down 39.4% year-over-year from $1.0 million in Q1 2025, and down 84.46% quarter-over-quarter from $3.9 million in Q4 2025.
OmniAb (OABI) Depreciation and Depletion (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Depreciation and Depletion data on file, last reported at $606000.0 in Q1 2026.
- Depreciation and Depletion for Q1 2026 came in at $606000.0, down 39.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.2 million (up 51.37% YoY), and the FY2025 annual result was $6.6 million, up 60.98% from the prior year.
- Depreciation and Depletion retreated to $606000.0 in Q1 2026 per OABI's latest filing, from $3.9 million in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $3.9 million in Q4 2025 and troughed at $600000.0 in Q1 2022.
- A 5-year average of $1.1 million and a median of $1.0 million in 2023 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2025 and 2026: Depreciation and Depletion jumped 290.0% in 2025, then plunged 39.4% in 2026.
- A 5-year view of Depreciation and Depletion shows it stood at $1.3 million in 2022, then fell by 23.08% to $1.0 million in 2023, then slipped by 0.0% to $1000000.0 in 2024, then jumped by 290.0% to $3.9 million in 2025, then tumbled by 84.46% to $606000.0 in 2026.
- Business Quant data shows OABI's Depreciation and Depletion at $606000.0 in Q1 2026, $3.9 million in Q4 2025, and $900000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 606,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 606,000.00 |
| Mar 31, 2026 | 606,000.00 |
| Dec 31, 2025 | 3.90 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 900,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 1,000,000.00 |
| Dec 31, 2024 | 1,000,000.00 |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |